Actively Recruiting
Study Comparing LightForce Therapy Lasers Plus Physiotherapy to Sham Laser Plus Physiotherapy for Reducing Shoulder Soft Tissue Inflammation Pain
Led by DJO UK Ltd · Updated on 2025-11-17
130
Participants Needed
10
Research Sites
17 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness of LightForce Therapy Lasers in reducing pain for people with shoulder soft tissue inflammation caused by Subacromial Impingement Syndrome SAIS or Rotator Cuff Tendinopathy RCT. This post-market, international, multi-center, prospective, randomized, sham-controlled, single-blind study also gathers safety and performance data for LightForce Therapy Lasers used according to their approved medical device regulations. Participants will receive either the active LightForce Therapy Laser treatment or a sham laser therapy, both combined with a standard physiotherapy and exercise program that includes Codmans pendulum exercises, range of motion, stretching, and isometric strengthening exercises. These interventions are delivered over 4 consecutive weeks, with at least 3 sessions per week. The study compares pain reduction between the two groups and monitors safety throughout. During the study, participants will be assessed for changes in pain 4 weeks after treatment start using visual analog scale VAS scores. Safety is tracked by recording any adverse events throughout an average 21-week period. Participants will follow the prescribed exercise and therapy sessions, and researchers will monitor performance and any side effects of the laser therapy to better understand its impact on shoulder soft tissue inflammation pain.
CONDITIONS
Brief Title
Performance and Safety of LightForce® Therapy Lasers on Shoulder Soft Tissue Inflammation Pain Reduction
Research Team
E
Elena Arcangeli
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here